Compare ADTN & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADTN | INSP |
|---|---|---|
| Founded | 1985 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medical/Dental Instruments |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1996 | 2018 |
| Metric | ADTN | INSP |
|---|---|---|
| Price | $15.42 | $42.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 16 |
| Target Price | $15.50 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 2.6M | 853.9K |
| Earning Date | 05-04-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 90.83 | ★ 179.43 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,083,807,000.00 | $82,050,000.00 |
| Revenue This Year | $11.09 | $8.02 |
| Revenue Next Year | $8.47 | $8.11 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 17.46 | ★ 62.18 |
| 52 Week Low | $7.11 | $38.91 |
| 52 Week High | $19.98 | $147.03 |
| Indicator | ADTN | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 48.40 | 44.13 |
| Support Level | $14.13 | $39.26 |
| Resistance Level | $16.28 | $44.98 |
| Average True Range (ATR) | 1.12 | 2.03 |
| MACD | -0.17 | 0.40 |
| Stochastic Oscillator | 29.58 | 55.52 |
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions segment, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support segment, which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions. It generates the majority of its revenue from the Network Solutions segment.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.